Bis(2-Bromoethyl)amine hydrobromide

Catalog No. :
ACWCBS257
CAS No. :
43204-63-3
Molecular Formula :
C4H10Br3N
Molecular Weight :
311.84

IUPAC Name:bis(2-bromoethyl)amine hydrobromide

Bis(2-Bromoethyl)amine hydrobromide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5g97%$131.00Login to see priceIn stockInquiry
10g97%$222.00Login to see priceInquiryInquiry
25g97%$445.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameBis(2-Bromoethyl)amine hydrobromide
IUPAC Namebis(2-bromoethyl)amine hydrobromide
MDL No.MFCD11044002
Molecular FormulaC4H10Br3N
Molecular Weight311.84
SMILESBrCCNCCBr.[H]Br
InChI KeyYHHKEXPNBPDPOW-UHFFFAOYSA-N
Synonymbis(2-bromoethyl)ammonium bromide;BIS(2-BROMOETHYL)AMINEHYDROBROMICACIDSALT;2-BROMO-N-(2-BROMOETHYL)ETHANAMINE HYDROBROMIDE;Bis(2-bromoethyl)amine·hydrobrominate;Bis(2-bromoethyl)amine hydrobromide;EthanaMine, 2-broMo-N-(2-broMoethyl)-, hydrobroMide;2,2'-Dibromodiethylamine Hydrobromide;Bis(2-bromoethyl)ammonium hydrobromide
CAS No.43204-63-3
PubChem CID12692731

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACWCBS257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSLZT681 route compound structure diagram
    ACSLZT6812576-47-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCBS257 route product structure diagram
    ACWCBS25743204-63-3 In Stock
Inquiry

2. ACWCBS257 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWCBS257 route product structure diagram
    ACWCBS25743204-63-3 In Stock
Inquiry

Comments (0)